Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129

Patients with p16-positive tumors had significantly higher pCR and locoregional control rates than those with p16-negative tumors.